Composition for topical administration

Details Composition for topical administration Composition for topical administration

2006-04-25

2006-04-25

Kim, Vickie (Department: 1614)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C514S291000, C514S312000, C514S772000, C424S401000

Reexamination Certificate

active

07033604

ABSTRACT:
The present invention provides a composition for topical administration comprising an interleukin 2 inhibitor and an antimicrobial agent as active ingredients thereof, wherein said interleukin 2 inhibitor contains a tricyclo compound as shown by the general formula (I) or pharmaceutically acceptable salt thereof. The present invention further provides a method for treating inflammations and/or infections comprising topical administration of an effective amount of an interleukin 2 inhibitor and an antimicrobial agent to a subject in need of the treatment of inflammations and/or infections.

REFERENCES:
patent: 5348966 (1994-09-01), Starzl et al.
patent: 5385907 (1995-01-01), Asakura et al.
patent: 5474764 (1995-12-01), Patel et al.
patent: 5514686 (1996-05-01), Mochizuki et al.
patent: 5880101 (1999-03-01), Stankov
patent: 5885601 (1999-03-01), Sokal
patent: 5912255 (1999-06-01), Bussell
patent: 5939427 (1999-08-01), Kagayama et al.
patent: 6017554 (2000-01-01), Ratcliff
patent: 6087358 (2000-07-01), Baker et al.
patent: 6140355 (2000-10-01), Egidio et al.
patent: 6174859 (2001-01-01), Lezdey et al.
patent: 6191143 (2001-02-01), Watts et al.
patent: 6248776 (2001-06-01), Harris
patent: 6312715 (2001-11-01), Cantor et al.
patent: 6359016 (2002-03-01), Singh et al.
patent: 6475518 (2002-11-01), Baumgart et al.
patent: 2003/0044452 (2003-03-01), Ueno
patent: 2003/0114416 (2003-06-01), Pulaski et al.
patent: 2004/0019054 (2004-01-01), Roark
patent: WO 00/50007 (2000-08-01), None
patent: WO00/66122 (2000-11-01), None
patent: WO 02/085359 (2002-10-01), None
patent: WO 00/66122 (2002-11-01), None
U.S. Copending Appl. No. 10/495,425 filed May 21, 2004 and U.S. Appl. No. 10/523,842 filed Feb. 8, 2005.
Interactions Between Tacrolimus and Antimicrobial Agents; David L. Paterson and Nina Singh; Dec. 1997; pp. 1430-1440.
Effects of Twenty-Three Drugs on The Metabolism of FK506 by Human Liver Microsomes; Kazuhide Iwasaki, Hiroji Matsuda, Kazuko Nagase, Toshifumi Shiraga, Yoji Tokuma, Kazuharu Uchida; Nov. 1993; pp. 209-216.
Norfloxacin interferes with cyclosporine disposition in pediatric patients undergoing renal transplantation; Roman A. McLellan, Robert K. Drobitch, D. Heather McLellan, Philip D. Acott, John F.S. Crocker, Kenneth W. Renton; 1995; pp. 322-327.
Pharmacokinetic Drug Interactions with Antimicrobial Agents; J. Gregory Gillum, Debra S. Israel, Ron E. Polk; 1993; pp. 450-482.
U.S. Appl. No. 10/495,425, filed May 21, 2004, Ueno.
U.S. Appl. No. 10/523,842, filed Feb. 8, 2005, Ueno.

Affiliated with

Also associated with

Rating

Composition for topical administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for topical administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for topical administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3597569